A new pathway of CD5 glycoprotein-mediated T cell inhibition dependent on inhibitory phosphorylation of Fyn kinase.

Triggering of the T cell receptor initiates a signaling cascade resulting in the activation of the T cell. These signals are integrated alongside those resulting from the triggering of other receptors whose function is to modulate the overall response. CD5 is an immunotyrosine-based inhibition motif...

ver descrição completa

Detalhes bibliográficos
Principais autores: Bamberger, M, Santos, A, Gonçalves, C, Oliveira, M, James, JR, Moreira, A, Lozano, F, Davis, S, Carmo, A
Formato: Journal article
Idioma:English
Publicado em: 2011
_version_ 1826260318382194688
author Bamberger, M
Santos, A
Gonçalves, C
Oliveira, M
James, JR
Moreira, A
Lozano, F
Davis, S
Carmo, A
author_facet Bamberger, M
Santos, A
Gonçalves, C
Oliveira, M
James, JR
Moreira, A
Lozano, F
Davis, S
Carmo, A
author_sort Bamberger, M
collection OXFORD
description Triggering of the T cell receptor initiates a signaling cascade resulting in the activation of the T cell. These signals are integrated alongside those resulting from the triggering of other receptors whose function is to modulate the overall response. CD5 is an immunotyrosine-based inhibition motif-bearing receptor that antagonizes the overt T cell receptor activation response by recruiting inhibitory intracellular mediators such as SHP-1, RasGAP, or Cbl. We now propose that the inhibitory effects of CD5 are also mediated by a parallel pathway that functions at the level of inhibition of Fyn, a kinase generally associated with T cell receptor-mediated activation. After CD5 ligation, phosphorylation of the negative regulatory tyrosine (Tyr(531)) of Fyn increases, and this correlates with a substantial reduction in the kinase activity of Fyn and a profound inhibition of ZAP-70 activation. The effect requires the last 23 amino acids of the cytoplasmic domain of the receptor, strongly implying the involvement of a new CD5-interacting signaling or adaptor protein. Furthermore, we show that upon CD5 ligation there is a profound shift in its distribution from the bulk fluid phase to the lipid raft environment, where it associates with Fyn, Lck, and PAG. We suggest that the relocation of CD5, which we also show is capable of forming homodimers, to the proximity of raft-resident molecules enables CD5 to inhibit membrane proximal signaling by controlling the phosphorylation and activity of Fyn, possibly by interfering with the disassembly of C-terminal Src kinase (Csk)-PAG-Fyn complexes during T cell activation.
first_indexed 2024-03-06T19:03:43Z
format Journal article
id oxford-uuid:146ac229-a89e-47c1-bcf7-af1b0b941cb8
institution University of Oxford
language English
last_indexed 2024-03-06T19:03:43Z
publishDate 2011
record_format dspace
spelling oxford-uuid:146ac229-a89e-47c1-bcf7-af1b0b941cb82022-03-26T10:19:41ZA new pathway of CD5 glycoprotein-mediated T cell inhibition dependent on inhibitory phosphorylation of Fyn kinase.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:146ac229-a89e-47c1-bcf7-af1b0b941cb8EnglishSymplectic Elements at Oxford2011Bamberger, MSantos, AGonçalves, COliveira, MJames, JRMoreira, ALozano, FDavis, SCarmo, ATriggering of the T cell receptor initiates a signaling cascade resulting in the activation of the T cell. These signals are integrated alongside those resulting from the triggering of other receptors whose function is to modulate the overall response. CD5 is an immunotyrosine-based inhibition motif-bearing receptor that antagonizes the overt T cell receptor activation response by recruiting inhibitory intracellular mediators such as SHP-1, RasGAP, or Cbl. We now propose that the inhibitory effects of CD5 are also mediated by a parallel pathway that functions at the level of inhibition of Fyn, a kinase generally associated with T cell receptor-mediated activation. After CD5 ligation, phosphorylation of the negative regulatory tyrosine (Tyr(531)) of Fyn increases, and this correlates with a substantial reduction in the kinase activity of Fyn and a profound inhibition of ZAP-70 activation. The effect requires the last 23 amino acids of the cytoplasmic domain of the receptor, strongly implying the involvement of a new CD5-interacting signaling or adaptor protein. Furthermore, we show that upon CD5 ligation there is a profound shift in its distribution from the bulk fluid phase to the lipid raft environment, where it associates with Fyn, Lck, and PAG. We suggest that the relocation of CD5, which we also show is capable of forming homodimers, to the proximity of raft-resident molecules enables CD5 to inhibit membrane proximal signaling by controlling the phosphorylation and activity of Fyn, possibly by interfering with the disassembly of C-terminal Src kinase (Csk)-PAG-Fyn complexes during T cell activation.
spellingShingle Bamberger, M
Santos, A
Gonçalves, C
Oliveira, M
James, JR
Moreira, A
Lozano, F
Davis, S
Carmo, A
A new pathway of CD5 glycoprotein-mediated T cell inhibition dependent on inhibitory phosphorylation of Fyn kinase.
title A new pathway of CD5 glycoprotein-mediated T cell inhibition dependent on inhibitory phosphorylation of Fyn kinase.
title_full A new pathway of CD5 glycoprotein-mediated T cell inhibition dependent on inhibitory phosphorylation of Fyn kinase.
title_fullStr A new pathway of CD5 glycoprotein-mediated T cell inhibition dependent on inhibitory phosphorylation of Fyn kinase.
title_full_unstemmed A new pathway of CD5 glycoprotein-mediated T cell inhibition dependent on inhibitory phosphorylation of Fyn kinase.
title_short A new pathway of CD5 glycoprotein-mediated T cell inhibition dependent on inhibitory phosphorylation of Fyn kinase.
title_sort new pathway of cd5 glycoprotein mediated t cell inhibition dependent on inhibitory phosphorylation of fyn kinase
work_keys_str_mv AT bambergerm anewpathwayofcd5glycoproteinmediatedtcellinhibitiondependentoninhibitoryphosphorylationoffynkinase
AT santosa anewpathwayofcd5glycoproteinmediatedtcellinhibitiondependentoninhibitoryphosphorylationoffynkinase
AT goncalvesc anewpathwayofcd5glycoproteinmediatedtcellinhibitiondependentoninhibitoryphosphorylationoffynkinase
AT oliveiram anewpathwayofcd5glycoproteinmediatedtcellinhibitiondependentoninhibitoryphosphorylationoffynkinase
AT jamesjr anewpathwayofcd5glycoproteinmediatedtcellinhibitiondependentoninhibitoryphosphorylationoffynkinase
AT moreiraa anewpathwayofcd5glycoproteinmediatedtcellinhibitiondependentoninhibitoryphosphorylationoffynkinase
AT lozanof anewpathwayofcd5glycoproteinmediatedtcellinhibitiondependentoninhibitoryphosphorylationoffynkinase
AT daviss anewpathwayofcd5glycoproteinmediatedtcellinhibitiondependentoninhibitoryphosphorylationoffynkinase
AT carmoa anewpathwayofcd5glycoproteinmediatedtcellinhibitiondependentoninhibitoryphosphorylationoffynkinase
AT bambergerm newpathwayofcd5glycoproteinmediatedtcellinhibitiondependentoninhibitoryphosphorylationoffynkinase
AT santosa newpathwayofcd5glycoproteinmediatedtcellinhibitiondependentoninhibitoryphosphorylationoffynkinase
AT goncalvesc newpathwayofcd5glycoproteinmediatedtcellinhibitiondependentoninhibitoryphosphorylationoffynkinase
AT oliveiram newpathwayofcd5glycoproteinmediatedtcellinhibitiondependentoninhibitoryphosphorylationoffynkinase
AT jamesjr newpathwayofcd5glycoproteinmediatedtcellinhibitiondependentoninhibitoryphosphorylationoffynkinase
AT moreiraa newpathwayofcd5glycoproteinmediatedtcellinhibitiondependentoninhibitoryphosphorylationoffynkinase
AT lozanof newpathwayofcd5glycoproteinmediatedtcellinhibitiondependentoninhibitoryphosphorylationoffynkinase
AT daviss newpathwayofcd5glycoproteinmediatedtcellinhibitiondependentoninhibitoryphosphorylationoffynkinase
AT carmoa newpathwayofcd5glycoproteinmediatedtcellinhibitiondependentoninhibitoryphosphorylationoffynkinase